• English
    X

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    ​​​

    Governor Hogan and CVS Health Announce 17 New Drive-Thru COVID-19 Testing Sites in Maryland

    Please note that details regarding COVID-19 testing continue to evolve to meet Marylanders’ needs, and changes may not be reflected in this point-in-time news release. For the most up-to-date information on testing in Maryland, click here. 

    Announcement Comes Two Days After Governor Hogan’s Order Authorizing Pharmacies in Maryland to Order and Administer COVID-19 Tests
    Appointment-Free Testing at State-Operated Drive-Thru Sites Begins Today at Timonium Fairgrounds

    ANNAPOLIS, MD—Governor Larry Hogan and CVS Health today announced 17 new COVID-19 test sites at select CVS Pharmacy drive-thru locations across Maryland. The opening of additional test sites across the state will be announced by the end of the month.

    This announcement comes two days after Governor Hogan signed an emergency order authorizing the state’s nearly 1,200 pharmacies to order and administer COVID-19 tests as part of Maryland’s long-term testing strategy. Beginning today at Timonium Fairgrounds in Baltimore County, state-operated drive-thru sites will be offering appointment-free COVID-19 testing, including for those who are asymptomatic.

    “Following our announcement that Maryland has reached a critical milestone in its long-term COVID-19 testing strategy by dramatically expanding the availability of testing for residents, these new, additional sites are another important step to further increase testing access for communities across Maryland,” said Governor Hogan. “We will continue working closely with CVS Health and all of our partners in the private sector, along with Maryland’s world-class health care systems and local governments, to protect residents’ health and safety and support our state’s safe and gradual recovery.”

    The CVS sites will utilize self-swab tests and mark the next phase of the company’s nationwide COVID-19 testing strategy, announced April 27. The 17 test sites in Maryland are part of nearly 350 locations across 14 states, including Arizona, California, Connecticut, Florida, Georgia, Illinois, Indiana, Louisiana, Maryland, Massachusetts, New Jersey, New York, Pennsylvania, and Texas.

    “While the large-scale test sites we’ve been operating since early April have proven successful, this new approach allows us to utilize our presence in communities across the country and bring testing closer to home,” said Larry J. Merlo, President and CEO of CVS Health. “Our frontline employees will continue to play a critical role in the testing process, with members of their communities directly benefiting from their dedication and selflessness.”

    Once fully operational, more than half of the company’s 1,000 test sites will serve communities with the greatest need for support, as measured by the CDC’s Social Vulnerability Index. The index tracks a variety of census variables, including poverty, lack of access to transportation, and crowded housing that may weaken a community’s ability to prepare for and recover from hazardous events like natural disasters and disease outbreaks.

    Self-swab tests will be available to individuals meeting Centers for Disease Control and Prevention criteria, in addition to age guidelines. Patients must register in advance at CVS.com beginning Friday, May 22 to schedule an appointment. Patients will be required to stay in their cars and directed to the pharmacy drive-thru window, where they will be provided with a test kit and given instructions. A CVS Pharmacy team member will observe the self-swab process to ensure it is done properly. Tests will be sent to an independent, third-party lab for processing and the results will be available in approximately three days.

    Testing will not take place inside any retail locations, and CVS Pharmacy, HealthHUB, and MinuteClinic will continue to serve customers and patients.

    The new testing sites in Maryland include:

    Anne Arundel County
    CVS Pharmacy, 2600 Annapolis Road, Severn, MD 21076
    CVS Pharmacy, 157 Ritchie Highway, Severna Park, MD 21146

    Baltimore City
    CVS Pharmacy, 9519 Philadelphia Road, Baltimore, MD 21237
    CVS Pharmacy, 2560 West Franklin Street, Baltimore, MD 21223

    Carroll County
    CVS Pharmacy, 6040 Sykesville Road, Eldersburg, MD 21784

    Charles County
    CVS Pharmacy, 4200 Altamont Place, White Plains, MD 20695

    Frederick County
    CVS Pharmacy, 8032 Liberty Road, Frederick, MD 21701
    CVS Pharmacy, 5414 Rotary Avenue, New Market, MD 21774

    Howard County
    CVS Pharmacy, 8197 Westside Boulevard, Fulton, MD 20759

    Montgomery County
    CVS Pharmacy, 7809 Wisconsin Avenue, Bethesda, MD 20814
    CVS Pharmacy, 799 Rockville Pike, Rockville, MD 20852
    CVS Pharmacy, 12215 Darnestown Road, Gaithersburg, MD 20878

    Prince George’s County
    CVS Pharmacy, 8201 Annapolis Road, New Carrollton, MD 20784
    CVS Pharmacy, 7600 SE Crain Highway, Upper Marlboro, MD 20772
    CVS Pharmacy, 4840 Marlboro Pike, Capitol Heights, MD 20743
    CVS Pharmacy, 5100 Brown Station Road, Upper Marlboro, MD 20772

    Worcester County
    CVS Pharmacy, 12001 Coastal Highway, Ocean City, MD 21842

    For more information on COVID-19 testing in Maryland, please visit https://coronavirus.maryland.gov/pages/symptoms-testing.

    -###-​